Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue ($)

Novartis revenue was $52.88 b in FY, 2021

FY, 2018FY, 2019FY, 2020FY, 2021
Revenue$53.17 b$50.49 b$49.9 b$52.88 b

Revenue Breakdown

Business Segment

Geographic Segment

Novartis revenue breakdown by business segment: 18.3% from SANDOZ and 81.7% from INNOVATIVE MEDICINES

Novartis revenue breakdown by geographic segment: 5.2% from JAPAN, 9.4% from GERMANY, 32.6% from UNITED STATES, 40.3% from OTHER/GROUPS, 5.9% from CHINA (PEOPLES REPUBLIC) and 6.6% from Other

FY, 2021FY, 2020FY, 2018FY, 2019
ELIMINATIONS($964 k)($813 k)($906 k)($847 k)
SANDOZ$9.87 m$9.89 m$10.1 m$9.94 m
INNOVATIVE MEDICINES$43.97 m$40.82 m$36.82 m$39.59 m
ALCON, INC.$7.15 m
FY, 2021FY, 2020FY, 2018FY, 2019
REST OF WORLD$22.17 m$1.23 m
SWITZERLAND$873 k$800 k$852 k$848 k
JAPAN$2.68 m$2.8 m$3.17 m$2.66 m
GERMANY$4.87 m$4.52 m$4.18 m$4.12 m
FRANCE$2.52 m$2.44 m$2.71 m$2.44 m
UNITED STATES$16.82 m$16.48 m$17.56 m$16.28 m
OTHER/GROUPS$20.81 m$21.61 m$1.27 m$21.1 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu